DeepMed Research

NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer

Phase 1

Recruiting

Conditions: Breast Cancer

Interventions: Device: QPOP

First Posted Date: 2022-01-04

Last Posted Date: 2023-04-18

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 26

Registration Number: NCT05177432

Locations: 🇸🇬
National University Hospital Singapore, Singapore, Singapore

Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements

Phase 1

Recruiting

Conditions: Solid Tumor

Interventions: Device: CURATE.AI
Drug: Nivolumab, Pembrolizumab

First Posted Date: 2022-01-03

Last Posted Date: 2023-03-03

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 10

Registration Number: NCT05175235

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Splint Versus Steroid Randomized Trial

Not Applicable

Conditions: De Quervain Syndrome

Interventions: Drug: Hydrocortisone-Lidocaine
Other: Splint

First Posted Date: 2021-12-21

Last Posted Date: 2022-03-09

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 100

Registration Number: NCT05165875

Cast Vs Splint in Distal Radius Fractures

Not Applicable

Conditions: Distal Radius Fracture

Interventions: Procedure: Cast vs Splint

First Posted Date: 2021-12-16

Last Posted Date: 2022-03-09

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 300

Registration Number: NCT05159310

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Effect of SynPhNe Physio-neuro Platform on Hand Motor Function Rehabilitation of Acute and Subacute Stroke Patients

Not Applicable

Recruiting

Conditions: Stroke

Interventions: Device: SynPhNe physio-neuro platform

First Posted Date: 2021-11-24

Last Posted Date: 2024-08-16

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 80

Registration Number: NCT05133232

Locations: 🇸🇬
Alexandra hospital, Singapore, Singapore

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Phase 1

Recruiting

Conditions: Advanced Hepatocellular Carcinoma

Interventions: Drug: MTL-CEBPA
Drug: Atezolizumab
Drug: Bevacizumab

First Posted Date: 2021-10-28

Last Posted Date: 2021-10-28

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 33

Registration Number: NCT05097911

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy

Not Applicable

Conditions: Chemotherapy-induced Peripheral Neuropathy

Interventions: Device: Paxman Cryocompression System (PCCS)

First Posted Date: 2021-10-27

Last Posted Date: 2021-11-12

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 33

Registration Number: NCT05095051

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Reducing Hypoxia in Patients With Coronavirus Disease (COVID-19) Using Topotecan With Standard of Care

Phase 1

Conditions: COVID-19 Respiratory Infection

Interventions: Drug: Topotecan

First Posted Date: 2021-10-19

Last Posted Date: 2021-11-04

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 24

Registration Number: NCT05083000

Locations: 🇮🇳
Christian Medical College, Vellore, Tamil Nadu, India

The Effect of A Dental Application to Promote Self-Administered Plaque Control: A RCT

Not Applicable

Completed

Conditions: Plaque, Dental
Periodontitis
Gingivitis

Interventions: Other: Mobile Dental Application, Dental Monitoring ("DM")

First Posted Date: 2021-10-11

Last Posted Date: 2022-02-15

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 52

Registration Number: NCT05073107

Locations: 🇸🇬
National University Hospital, Singapore, Singapore, Singapore

Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients

Conditions: Colorectal Cancer

First Posted Date: 2021-09-21

Last Posted Date: 2021-10-05

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 40

Registration Number: NCT05051592

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy